As shown in Figure 2, we found that SGO1 expression was correlated with pathological stages in several tumor types, including ACC (adrenocortical carcinoma), BRCA, KICH (kidney chromophobe), KIRC, KIRP, LIHC, LUAD, OV, PAAD (pancreatic adenocarcinoma), SKCM (skin cutaneous melanoma), and TGCT (testicular germ cell tumors). Here, SGO1 is linked to pancreatic adenocarcinoma.